| Drug design strategies to avoid resistance in direct-acting antivirals and beyond AN Matthew, F Leidner, GJ Lockbaum, M Henes, J Zephyr, S Hou, ... Chemical reviews 121 (6), 3238-3270, 2021 | 51 | 2021 |
| Hepatitis C virus NS3/4A protease inhibitors incorporating flexible P2 quinoxalines target drug resistant viral variants AN Matthew, J Zephyr, CJ Hill, M Jahangir, A Newton, CJ Petropoulos, ... Journal of medicinal chemistry 60 (13), 5699-5716, 2017 | 46 | 2017 |
| Molecular mechanism of resistance in a clinically significant double-mutant variant of HCV NS3/4A protease AN Matthew, F Leidner, A Newton, CJ Petropoulos, W Huang, A Ali, ... Structure 26 (10), 1360-1372. e5, 2018 | 20 | 2018 |
| Avoiding drug resistance by substrate envelope-guided design: toward potent and robust HCV NS3/4A protease inhibitors AN Matthew, J Zephyr, D Nageswara Rao, M Henes, W Kamran, ... MBio 11 (2), 10.1128/mbio. 00172-20, 2020 | 18 | 2020 |
| Quinoxaline-based linear HCV NS3/4A protease inhibitors exhibit potent activity against drug resistant variants LN Rusere, AN Matthew, GJ Lockbaum, M Jahangir, A Newton, ... ACS Medicinal Chemistry Letters 9 (7), 691-696, 2018 | 18 | 2018 |
| Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors A Özen, K Prachanronarong, AN Matthew, DI Soumana, CA Schiffer Critical reviews in biochemistry and molecular biology 54 (1), 11-26, 2019 | 16 | 2019 |
| Discovery of quinoxaline-based p1–p3 macrocyclic ns3/4a protease inhibitors with potent activity against drug-resistant hepatitis C virus variants D Nageswara Rao, J Zephyr, M Henes, ET Chan, AN Matthew, ... Journal of medicinal chemistry 64 (16), 11972-11989, 2021 | 11 | 2021 |
| Mavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C Infection: Published as part of the Biochemistry series “Biochemistry to Bedside” AN Matthew, N Kurt Yilmaz, CA Schiffer Biochemistry 57 (5), 481-482, 2018 | 11 | 2018 |
| An overview of the ASU features testbed J Shah, M Rogers, P Sreevalsan, D Hsiao, A Matthew, A Bhatanagar, ... Proc. 1990 ASME Computers in Engineering Conference, 233-242, 1990 | 7 | 1990 |
| Deciphering the molecular mechanism of HCV protease inhibitor Fluorination as a general approach to avoid drug resistance J Zephyr, DN Rao, SV Vo, M Henes, K Kosovrasti, AN Matthew, ... Journal of molecular biology 434 (9), 167503, 2022 | 6 | 2022 |
| Avoiding drug resistance by substrate envelope-guided design: toward potent and robust HCV NS3/4A protease inhibitors. mBio 11 (2): e00172-20 AN Matthew, J Zephyr, D Nageswara Rao, M Henes, W Kamran, ... | 6 | 2020 |
| Evolution of robotic-assisted kidney transplant: successes and barriers to overcome AN Matthew, LJ Hampton, R Autorino, CS Bhati Current Opinion in Urology 31 (1), 29-36, 2021 | 3 | 2021 |
| Purification of metal-dependent lysine deacetylases with consistently high activity TB Toro, RG Painter, RA Haynes, EY Glotser, MR Bratton, JR Bryant, ... Protein expression and purification 141, 1-6, 2018 | 3 | 2018 |
| The use of low-intensity extracorporeal shockwave therapy in management of erectile dysfunction following prostate cancer treatment: a review of the current literature AN Matthew, DE Rogers, G Grob, M Blottner, S Kodama, SC Krzastek Translational Andrology and Urology 12 (6), 1023, 2023 | 2 | 2023 |
| Paraurethral mass: A case of urethral leiomyoma surgical approach AN Matthew, LN Siff International Urogynecology Journal 33 (5), 1351-1352, 2022 | 1 | 2022 |
| Perioperative infection prevention during inflatable penile prosthesis surgery: a narrative review AN Matthew-Onabanjo, AN Matthew, E Famati, V Nguyen, MJ Rogers Translational Andrology and Urology 13 (8), 1628640-1621640, 2024 | | 2024 |
| MP66-14 MARKERS OF NEOVASCULARIZATION AND NEUROGENESIS MAY CHANGE AFTER LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE THERAPY FOR ERECTILE DYSFUNCTION A Matthew, S Coffey, T Nguyen, P Sapao, AP Klausner, RP Smith, ... Journal of Urology 211 (5S), e1091, 2024 | | 2024 |
| MP59-17 HEMODYNAMIC DIFFERENCES IN WOMEN WITH AND WITHOUT URINARY URGENCY CAN BE DETECTED USING NEAR INFRARED SPECTROSCOPY (NIRS) DURING BLADDER FILLING LS Burkett, L Mortemousque, J Dare, P Daniels, H Query, M Ghatas, ... Journal of Urology 211 (5S), e964, 2024 | | 2024 |
| PD12-10 BLADDER WALL MICROMOTION CAN BE REPRODUCED USING AN EX-VIVO PERFUSED PORCINE BLADDER RW Fogg, B McCormack, M Shields, A Matthew, G Grob, N Araia, ... The Journal of Urology 211 (5S), e260, 2024 | | 2024 |
| PD43-05 VARIATIONS IN BRAIN AND BLADDER NEAR INFRARED SPECTROSCOPY (NIRS) CAN BE USED TO POTENTIALLY CATEGORIZE ORGAN-SPECIFIC SUBTYPES OF OAB LS Burkett, P Daniels, H Query, M Ghatas, G Grob, A Matthew, D Rogers, ... Journal of Urology 211 (5S), e900, 2024 | | 2024 |
